Content |
Owners
Frenova develops medicines and the equipment for researches in the field of diseases of kidneys and the related statuses, such as anemia, complications of diabetes, inflammation and violation of metabolism and also solutions for carrying out dialysis in house conditions and devices of vascular access.
History
2019: Fresenius is going to integrate "under a wing" Frenova activity about 550 researchers
The Fresenius Medical Care company ("Frezenius Medikal Kea"), the specialist in the field of dialysis, announced plans of expansion in the field of the international clinical trials and consolidation of research activity in Latin America, Europe, in the Middle East and in Africa within Frenova subsidiary company (Frenov) what became known on July 9, 2019.
The contract research organization of Frenova Renal Research will be integrated into the global medical department of Fresenius created at the beginning of 2019 for coordination of clinical trials and exchange of experience in network of clinics of dialysis.
"Under a wing" Frenova will be joint activity about 550 researchers in 350 clinical centers[1].
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |